Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

136 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A Prospective Study of 18F-DCFPyL PSMA PET/CT Restaging in Recurrent Prostate Cancer following Primary External Beam Radiotherapy or Brachytherapy.
Liu W, Zukotynski K, Emmett L, Chung HT, Chung P, Wolfson R, Rachinsky I, Kapoor A, Metser U, Loblaw A, Morton G, Sexton T, Lock M, Helou J, Berlin A, Boylan C, Archer S, Pond GR, Bauman G. Liu W, et al. Among authors: zukotynski k. Int J Radiat Oncol Biol Phys. 2020 Mar 1;106(3):546-555. doi: 10.1016/j.ijrobp.2019.11.001. Epub 2019 Nov 12. Int J Radiat Oncol Biol Phys. 2020. PMID: 31730876
Imaging in prostate carcinoma.
Zukotynski K, Haider MA. Zukotynski K, et al. Hematol Oncol Clin North Am. 2013 Dec;27(6):1163-87, vii-viii. doi: 10.1016/j.hoc.2013.08.003. Hematol Oncol Clin North Am. 2013. PMID: 24188257 Review.
PET/CT of Dementia.
Zukotynski K, Kuo PH, Mikulis D, Rosa-Neto P, Strafella AP, Subramaniam RM, Black SE. Zukotynski K, et al. AJR Am J Roentgenol. 2018 Aug;211(2):246-259. doi: 10.2214/AJR.18.19822. Epub 2018 Jun 27. AJR Am J Roentgenol. 2018. PMID: 29949415 Review.
18F-DCFPyL PET/CT in Oncocytoma.
Li J, Xu R, Kim CK, Bénard F, Kapoor A, Bauman G, Zukotynski KA. Li J, et al. Among authors: zukotynski ka. Clin Nucl Med. 2018 Dec;43(12):921-924. doi: 10.1097/RLU.0000000000002301. Clin Nucl Med. 2018. PMID: 30300203
Utilization of Salvage and Systemic Therapies for Recurrent Prostate Cancer as a Result of 18F-DCFPyL PET/CT Restaging.
Liu W, Zukotynski K, Emmett L, Chung HT, Chung P, Wolfson R, Rachinsky I, Kapoor A, Metser U, Loblaw A, Morton G, Sexton T, Lock M, Helou J, Berlin A, Boylan C, Archer S, Pond GR, Bauman G. Liu W, et al. Among authors: zukotynski k. Adv Radiat Oncol. 2020 Sep 9;6(1):100553. doi: 10.1016/j.adro.2020.08.010. eCollection 2021 Jan-Feb. Adv Radiat Oncol. 2020. PMID: 33521396 Free PMC article.
Prospective, Single-Arm Trial Evaluating Changes in Uptake Patterns on Prostate-Specific Membrane Antigen-Targeted 18F-DCFPyL PET/CT in Patients with Castration-Resistant Prostate Cancer Starting Abiraterone or Enzalutamide.
Zukotynski KA, Emmenegger U, Hotte S, Kapoor A, Fu W, Blackford AL, Valliant J, Bénard F, Kim CK, Markowski MC, Eisenberger MA, Antonarakis ES, Pienta KJ, Gorin MA, Lubanovic M, Kim J, Pomper MG, Cho SY, Rowe SP. Zukotynski KA, et al. J Nucl Med. 2021 Oct;62(10):1430-1437. doi: 10.2967/jnumed.120.259069. Epub 2021 Feb 19. J Nucl Med. 2021. PMID: 33608426 Free PMC article. Clinical Trial.
136 results